Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
Status:
Not yet recruiting
Trial end date:
2021-09-17
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the visual outcome and prognostic factors after
intraocular injections of Ranibizumab or combination of Ranibizumab And Dexamethasone under
pro re nata treatment regimen for Diabetic Macular Edema patients.